Variable | Univariate analysis | Bivariate analysis | ||
OR (95% CI) | P-value | OR (95% CI) | P-value | |
Age | 1.03 (1.01 ± 1.05) | 0.01 | 1.00 (0.97 ± 1.02) | 0.83 |
Gender | 1.78 (1.05 ± 3.01) | 0.03 | 1.29 (0.71 ± 2.36) | 0.40 |
High blood pressure | 1.60 (1.05 ± 2.46) | 0.03 | 0.58 (0.12 ± 2.90) | 0.51 |
Antihypertensive medication | 1.76 (1.14 ± 2.70) | 0.01 |
|
|
Heart rate | 1.04 (1.02 ± 1.06) | 0.01 | 1.03 (1.01 ± 1.05) | 0.43 |
Leukocyte, 109/L | 1.09 (1.02 ± 1.17) | 0.01 | 0.94 (0.84 ± 1.04) | 0.20 |
Monocytes, 109/L | 2.89 (1.37 ± 6.09) | 0.01 | 2.39 (0.92 ± 6.21) | 0.10 |
Lymphocytes, 109/L | 1.33 (1.01 ± 1.75) | 0.05 |
|
|
Platelets, 109/L | 1.00 (1.00 ± 1.01) | 0.05 |
|
|
LDL-C, mmol/L | 1.28 (1.04 ± 1.58) | 0.02 |
|
|
ApoB, g/L | 2.13 (1.14 ± 3.95) | 0.02 | 2.63 (0.82 ± 8.42) | 0.10 |
LVEF, % | 0.97 (0.94 ± 0.99) | 0.00 |
| 0.48 |
non-proBNP, pg/ml | 1.00 (1.00 ± 1.00) | 0.00 | 0.99 (0.96 ± 1.03) | 0.75 |
ADAMTS-5 | 1.06 (1.04 ± 1.09) | 0.00 | 1.057 (1.028 ± 1.087) | 0.04 |